The authors further demonstrated that TMPRSS2 inhibition by hepatocyte growth factor activator inhibitor-2 abrogates the TMPRSS2-induced invasion of the prostate cancer cells and that activated matriptase levels correlate with TMPRSS2 expression in LNCaP and VCaP prostate cancer cells [268]. This evidence concerns the gene SPINT2 and prostate cancer.